Results 271 to 280 of about 41,992 (300)

Special Issue: Abstracts of the 11^th Congress of the European Academy of Neurology, Helsinki, Finland. [PDF]

Eur J Neurol
europepmc   +1 more source

GCN2-Mediated eIF2α Phosphorylation Is Required for Central Nervous System Remyelination. [PDF]

Int J Mol Sci
Falcón P, Brito Á, Escandón M, Roa JF, Martínez NW, Tapia-Godoy A, Farfán P, Matus S.   +7 more
europepmc   +1 more source

Synergistic Effects of Olfactory Ecto-Mesenchymal Stem Cell Supernatant and Ellagic Acid on Demyelination and Glial Modulation in a Chronic Multiple Sclerosis Model. [PDF]

Cell Mol Neurobiol
Tahmasebi F, Asl ER, Faghihi F, Bolandi N, Barati S.   +4 more
europepmc   +1 more source

Intrinsic retinoic acid synthesis is required for oligodendrocyte progenitor expansion during CNS remyelination. [PDF]

Front Cell Neurosci
Nanescu SE, Wathieu NM, Rosko L, Cha DS, Kumar MN, Olszewski RT, Reger J, Baydyuk M, Dua AN, Krezel W, Zujovic V, Huang JK.   +11 more
europepmc   +1 more source

Exploratory analysis of biological age measures in a remyelination clinical trial. [PDF]

Brain Commun
McMurran CE, de Meo E, Cunniffe NG, Brown JWL, Prados F, Kanber B, Cole JH, Coles AJ, Hägg S, Chard DT.   +9 more
europepmc   +1 more source

The Cambridge Centre for Myelin Repair trial Two (CCMR Two): a trial protocol for a phase 2a, randomised, double-blind, placebo-controlled clinical trial of the ability of the combination of metformin and clemastine to promote remyelination in people with relapsing-remitting multiple sclerosis already on disease-modifying therapy

Riboni-Verri G, McMurran CE, Mukherjee T, Daruwalla C, Holland J, Gautam R, Chen BS, Cutting E, Qian W, MacManus D, Chard DT, Brown JWL, Coles AJ, Cunniffe NG.   +13 more
europepmc   +1 more source

Microglia/Macrophages in Autoimmune Demyelinating Encephalomyelitis (Multiple Sclerosis/Neuromyelitis Optica). [PDF]

Int J Mol Sci
Yamasaki R.
europepmc   +1 more source

Longitudinal Analysis of P100 Wave Amplitude and Latency in Multiple Sclerosis: A 19-Year Retrospective VEP Study. [PDF]

Diagnostics (Basel)
Ciapă MA, Donica VC, Costea CF, Bogdănici CM.   +3 more
europepmc   +1 more source

Complement inhibition rapidly blocks lesion extension and facilitates remyelination in neuromyelitis optica. [PDF]

Acta Neuropathol Commun
Given KS, Acker EG, Macklin WB, Carlin D, Owens GP, Bennett JL.   +5 more
europepmc   +1 more source

Positive effect of evobrutinib in CNS remyelination models and lack of synergy with clemastine-A dose response study. [PDF]

Mult Scler J Exp Transl Clin
Martin E, Aigrot MS, Frère N, Lepaulmier R, Stankoff B, Boschert U, Lubetzki C, Zalc B.   +7 more
europepmc   +1 more source